Three, global pandemic time our At financial much on consisted operations. their we as world, year family we stronger those four, goals, begin took and would later, that as can now transform and and Matt, cash emerge Two, as outlined the worst and a pandemic, say we do ever. up business shortfalls, year, to conserve over that bioproduction not production catch everyone our keep is of much a four we Xtant goals and last A to good position. stronger as possible. morning Thank in listening. one, from people back goals the look our following; hardware only operational and this this as you, Medical Xtant safe. the of Those but meet than
the distribution a is the for much initiatives business needed Xtant growth our of point our transformation operational financial future initiatives several on position. private expansion innovative $XX February to and to brought products, placement we our Case capital focused Our million new implementation with closed in in designed growth network. of underwent position support strengthen and and that strategic significant in
rates. interest on we more and In debt addition, million financing $XX favorable week, and closed of terms last
impacted Now the across results, COVID reduction our markets sales turning our as elective serve. top of quarter slow first we procedures of hospitalizations the were by to the increase to off started spinal the
is a spinal which saw months two and of have However, of the nature procedures, of first solid indicating of in compared March other rebound April, elective procedures indicative recovery procedures. the a we typically quicker This from rebound a the to sales year.
customers highest the we number other In over past fact, with did in of business the month any year. than March
future of upcoming our growth. we focus COVID, a steps will an initiatives we believe commercial part While have that we through continue the necessary as to operational of to take managing from drive in shift several focus the impacts
introductions and product that product OsteoVive First, two PLUS. improve offering. several and the year, biologics lines we portfolio our new SI are advancing will Last launched Matriform the expand new of we release
four release in growth some contribute ahead. to products the plans years in have will new meaningful XXXX, that biologic We to including revenue we exciting believe products
markets well. distributors profitably, and our the open up network. helping We our touch distribution markets. and more expanding Xtant meetings. plan as our at to help our model in customers We and grow of committed other our grow reengage high shows trade product distributors do marketing We their enable process products existing greater showcase and program regional leading we're as turn our believe in programs Second, incentive in and to revamped penetration service continue with to that drive and national remain help will releases to
markets In these team country our rebuilding to where the and we're pandemic we of see position, at actions promising supported aggressive of in reduce the the our by plans, salesforce. process commercial by costs, marketing start addition the across opportunities. excited into took to our expanding adjacent stronger reinvest the talent to in regions we and we're in new After financial bringing
Looking can ahead, commercial be position we growth execution. to we're in a and on pleased where focus
that grow us give our the over the substantially initiatives confidence we strategic can business Our long-term.
our months, Over work continue costs and to will manage prudently to our mitigate while adjacent COVID-XX advantage the markets. growth opportunities of and of we the taking target pandemic, within impact coming
XXXX over for first quarter the like a call our CFO, would Jensen to results. I discussion Greg financial of Now our to turn